Survival after Elective Transjugular Intrahepatic Portosystemic Shunt Creation: Prediction with Model for End-Stage Liver Disease Score

Radiology

Volumn 231, Issue 1, 2004, Pages 231-236

  Ferral, Hector ^a,e   Gamboa, Pablo ^c   Postoak, Darren W ^a   Albernaz, Vanessa S ^d   Young, Carmen R ^a   Speeg, Kermitt V ^b   McMahan, C Alex ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

^e NONE   (United States)

Author keywords

Hypertension, portal; Liver, interventional procedures; Shunts, portosystemic

Indexed keywords

ACCURACY; ADULT; ARTICLE; ASCITES; COMPARATIVE STUDY; CONTROLLED STUDY; EMERGENCY TREATMENT; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL ANALYSIS; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ASCITES; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURGICAL PROCEDURES, ELECTIVE; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 1642318026     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2311030967     Document Type: Article

References (20)

1. Rossle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 1998; 18:73-89.
2. Encarnacion CE, Palmaz JC, Rivera FJ, et al. Transjugular intrahepatic portosystemic shunt placement for variceal bleeding: predictors of mortality. J Vasc Interv Radiol 1995; 6:687-694.
3. Rajan DK, Haskal ZJ, Clark TWI. Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis. J Vasc Interv Radiol 2002; 13:155-161.
4. Rubin RA, Haskal ZJ, O'Brien C, Cope C, Brass C. Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE 11 scores. Am J Gastroenterol 1995; 90:556-563.
5. Chalasani N, Clark WS, Martin LG, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118:138-144.
6. Patch D, Nikolopoulou V, McCormick A, et al. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol 1998; 28:454-460.
7. Coldwell DM, Ring EJ, Rees CR, et al. Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in management of portal hypertension. Radiology 1995; 196:335-340.
8. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470.
9. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871.
10. Salerno F, Merli M, Cazzaniga M, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002; 36:494-500.
11. Ferral H, Vasan R, Speeg KV, et al. Evaluation of a model to predict poor survival in patients undergoing elective TIPS procedures. J Vasc Interv Radiol 2002; 13:1103-1108.
12. Angermayr B, Cejna M, Karnel F, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003; 52:879-885.
13. Runyon BA. Care of patients with ascites. N Engl J Med 1994; 330:337-342.
14. Sanyal AJ, Genning C, Reddy KR, et al. The North American Study for the Treatment of Refractory Ascites. Gastroenterology 2003; 124:634-641.
15. Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123:1839-1847.
16. Ferral H, Bjarnason H, Wegryn SA, et al. Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 1993; 189:795-801.
17. Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from Child to MELD. Hepatology 2001; 33:473-475.
18. Walser EM, DeLa Pena R, Villanueva-Meyer J, Ozkan O, Soloway R. Hepatic perfusion before and after the transjugular intrahepatic portosystemic shunt procedure: impact on survival. J Vasc Interv Radiol 2000; 11:913-918.
19. Haskal ZJ, Martin L, Cardella JF, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2001; 12:131-136.
20. Zipprich A, Steudel N, Behrmann C, et al. Functional significance of hepatic arterial flow reserve in patients with cirrhosis. Hepatology 2003; 37:385-392.